Itron (ITRI) Q3 2026 Earnings Call Transcript

Itron reported Q3 revenue of $599 million, up 3% year over year and at the top of its outlook, while non-GAAP EPS of $1.94 exceeded management expectations and adjusted EBITDA set a quarterly record at $115 million. ARR grew 25% to $423 million, adjusted gross margin rose 350 basis points to 41.3%, and the company raised its full-year non-GAAP EPS outlook to $6.72–$6.82 while narrowing its revenue range to $2.37–$2.385 billion. Free cash flow declined to $96 million from $113 million, and management cited rising memory and selected component costs, partly offset by pricing and productivity measures.

Analysis

The more investable signal is mix and earnings conversion, not the quarterly revenue beat: recurring software/services adoption and operational efficiencies are lifting profit faster than sales. But the durability claim still needs proof in cash. Working-capital drag and lower interest income reduced free cash flow, while rising memory/component costs test whether pricing can protect margins. Track cash conversion alongside adjusted margin; one strong quarter does not establish a permanently higher earnings floor.

Itron’s compatibility strategy may defend incumbency by avoiding an uneconomic rip-and-replace for utilities. The trade-off is slower, less lumpy bookings rather than a single large award; value depends on continued attach of software and services to the installed base. Gas awards are a 2–3-year catalyst, with rollout and revenue further out, not a near-term estimate revision. The PG&E expansion supports product relevance, but “thousands” of endpoints alone does not establish material consolidated revenue.

Near term, Q4 revenue growth guidance is constructive, but higher seasonal operating expense and a lower EPS range than Q3 can temper the reaction. Over 1–3 months, bookings quality and 2027 guidance matter more than headline backlog. Over 6–18 months, recurring-revenue conversion and gas deployments are the structural test. Component inflation, regulatory delays, weaker utility budgets, or cellular substitution could reverse the thesis. No valuation or consensus data is provided, so avoid assuming the earnings beat is underpriced.

Key Decisions for Investors

• ITRI: Prefer a staged long on post-earnings consolidation rather than chasing the beat; keep sizing conditional on valuation. Reassess if adjusted gross margin retreats materially from the Q3 level or management indicates pricing/productivity is not offsetting component inflation.
• Use bookings and cash conversion as the 1–3 month alerts: verify Q4 awards are not merely timing-driven, and whether working capital normalizes. A weak Q4 book-to-bill trend or another decline in free cash flow despite earnings growth would weaken the long thesis.
• Treat gas deployments and recurring-revenue growth as medium-term catalysts, not booked revenue today. Look for evidence in 2027 guidance that ARR growth translates into sustained segment growth and cash generation; otherwise, the software-platform multiple narrative may be ahead of fundamentals.
• PCG and EXC: Do not trade the utilities on this disclosure alone. The deployments may improve grid visibility and resilience, but the article gives no quantified cost savings, capex impact, or material revenue contribution to either utility.